AliveDx

With over 30 years in in-vitro diagnostics, AliveDx creates innovative solutions that shorten the time to diagnosis. Discover our Alba and MosaiQ® brands.

[AliveDx @AliveDx_com]

Excited to announce AliveDx’s new partnership with Medipac Technologies Ltd, bringing our MosaiQ® & LumiQ® platforms to Bangladesh. A key step in expanding access to advanced diagnostics.
More here: https://t.co/qiZ8iHvuSe

[AliveDx @AliveDx_com]

Thrilled to share that AliveDx has been recognised as one of the UK’s Best Workplaces in BioPharma™ 2025 by @GPTW_UK! 🏆

This celebrates the culture our people have built—where innovation thrives & ideas are valued. 💙

Full list 👉 https://t.co/A3GGcfPpmC

#UKBestWorkplaces

[AliveDx @AliveDx_com]

🩺 Let’s talk about autoimmune connective tissue diseases (CTD).

CTDs like SLE, SjS, SSc & RA are complex, with non-specific symptoms that make diagnosis challenging.
AiPlex® CTDplus for MosaiQ® helps reduce time-to-diagnosis for patients.

👉 Learn more: https://t.co/DEvBcAMdwR

[AliveDx @AliveDx_com]

AliveDx announces FDA 510(k) submission for its MosaiQ AiPlex® Vasculitis (VAS) assay*.
*This product is not currently available in the USA, cleared or approved by the U.S. Food and Drug Administration (FDA) for clinical use. 
🔗https://t.co/dYxNE46w5J

[AliveDx @AliveDx_com]

Excited for the 17th Dresden Symposium on Autoantibodies! We’re presenting 5 posters, incl. a special poster tour on Sept 9, 12:00–13:30 CEST.
Visit Booth #11 & speak with our experts!
🔗 https://t.co/lXYntIJ1om

#DresdenSymposium #Autoantibodies #Diagnostics

[AliveDx @AliveDx_com]

Join us at #APLAR2025 in Fukuoka!
✨ Poster highlights (Sep 5):
🔹 MosaiQ AiPlex® CTD – Strong concordance + streamlined workflows. (10:50–11:10 & 13:40–14:10)
🔹 LumiQ – Promising ANA kit performance; future automation ahead. (14:30–15:10 & 16:30–16:55)
💬https://t.co/NkFzUfBYaS

[AliveDx @AliveDx_com]

Happy #LaborDay!

We honour the hard work and achievements of people everywhere—with a special thank you to those advancing healthcare and making a difference every day. 💙

[AliveDx @AliveDx_com]

🌏 Heading to APLAR 2025 in Fukuoka, Sept 3–7?
📌 Dr. Gerber Gomez will present 2 posters:
1️⃣ ANA HEp-2 substrate Kit performance for a new IFA-Analyzer
2️⃣ Multiplex microarray-immunoassay for 11 CTD-autoantibodies in Malaysia
#APLAR2025 #Rheumatology

[AliveDx @AliveDx_com]

Excited for #SSAI2025 in Lausanne tomorrow! 🎉

Our Scientific & Medical Officer, Dr. Gerber Gomez, will be there—join us at the poster sessions to learn more.
👉 Stop by our posters to learn more, or check out the abstract on our website: https://t.co/LUeZzJwXnm

[AliveDx @AliveDx_com]

🤝 AliveDx strengthens its collaboration with Transmedic through a second distribution agreement of the MosaiQ® and LumiQ® throughout Southeast Asia. 🌍

Read the full story here: https://t.co/56fIsMObiV

[AliveDx @AliveDx_com]

📢 Big milestone for AliveDx!
AliveDx registers MosaiQ®, its Instrument for Multiplex Testing of Autoimmune Diseases, Allergies and Beyond, as a Class II Exempt Device with the U.S. Food and Drug Administration (FDA)

🔗Read the full press release here: https://t.co/2LJJXchs6L

[AliveDx @AliveDx_com]

We're delighted to share that our Scientific & Medical Officer Dr. Gerber Gomez will present at #SSAI2025 in Lausanne.
📍 Thurs: Guided tour of his poster on:
👉 Machine Learning Classification using a 15-Autoantibody Profile for Autoimmune CTD Diagnosis.
Don’t miss it!

[AliveDx @AliveDx_com]

Celiac disease: 1 in 100 affected worldwide.
Hard to diagnose. Life-changing if detected early.

AiPlex® CD = Fast, easy, comprehensive testing.
✔ IgA + IgG in one test
✔ Fast results
✔ Clear insights

Find out more: https://t.co/mZjzdi0hjz

[AliveDx @AliveDx_com]

Designed to enhance efficiency, accuracy, and speed, our MosaiQ® and LumiQ® cutting-edge solutions aim to revolutionize autoimmune disease diagnostic testing. Would you like to learn more?
Contact our experts today!
🔗https://t.co/NkFzUfBYaS

[AliveDx @AliveDx_com]

#AMLI2025 was a success!
We raised awareness in autoimmune diagnostics and showcased our LumiQ® + MosaiQ® solutions.
Thanks to all who visited our booth and chatted with our USA sales team.
👉 Missed us? Connect with our team to find out more:
https://t.co/NkFzUfBYaS

[AliveDx @AliveDx_com]

Have you heard the news? MosaiQ AiPlex® VAS multiplex assay, now IVDR-CE marked.
A new milestone in our autoimmune diseases portfolio now covering autoimmune vasculitis diagnostics.

Want to learn more about our solutions and how they can help you?
🔗https://t.co/FWhoeQ69pZ

[AliveDx @AliveDx_com]

Ready to take a quantum leap in autoimmune & allergy diagnostics? 🚀
Meet AliveDx at AMLI 2025, booth #12, & explore our fully automated solutions for efficiency, accuracy & better patient care.
Book a meeting with us: https://t.co/Sp3mhMWgeu

[AliveDx @AliveDx_com]

AliveDx & Vital Care sign a second distribution deal — now bringing LumiQ® alongside MosaiQ® to deliver next-gen diagnostic solutions!

Together, these platforms simplify workflows and elevate patient care.

🔗 Read more here: https://t.co/5PRJH42V2K

[AliveDx @AliveDx_com]

Heading to AMLI 2025? Visit AliveDx at booth #12 to discover our all-in-one immunofluorescence solution for autoimmune disease diagnostics.

Book a meeting with us: https://t.co/MNkxhz3tS7

[AliveDx @AliveDx_com]

Big news! AliveDx signs a strategic distribution deal with @MediServKSA to bring MosaiQ® & LumiQ® diagnostics to Saudi Arabia.

A major step in expanding our impact in the Middle East!
🔗https://t.co/UYL6r3GLz9